Dexamethasone/Moxifloxacin

地塞米松/莫西沙星

Report date: 2026/04/17 20:02:02

Base Information

Drug NameDexamethasone/Moxifloxacin
Drug Alias NameMoxifloxacin/dexamethasone莫西沙星/地塞米松moxifloxacin and dexamethasone地塞米松莫西沙星Dexamethasone and Moxifloxacin +[8] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitors
TargetsGlucocorticoid receptorTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsPostoperative inflammationOcular inflammationCataract +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMexicoBrazil +[4] 
CombinationsYes DexamethasoneMoxifloxacin Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaPreclinical
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Sophia Sa De CvAlconEms +[4] 
Inactive CompaniesN/A
Active IndicationsPostoperative inflammationOcular inflammationCataract +[4] 
Inactive IndicationsOtitis Media

Other Information

ATC CodeD07CB04S01CA01S02CA06 +[4] 
Related LinksN/A